University Hospitals KU Leuven
Guidelines on the acute and long-term pharmacological treatment of acute mesenteric ischaemia (AMI) recommend the use of thrombolytic, antiplatelet or anticoagulant therapy depending on the aetiology of AMI and the use of stenting but only few details are given on the choice of the drug, dose and duration of treatment. Besides, recommendations are mainly based on data on coronary, cerebral and other peripheral artery diseases and do also not take into account the altered drug absorption in patients with short bowel syndrome, in which AMI can result.This case-based survey will inform us on the current international clinical practice of long-term antithrombotic management of AMI.
Acute Mesenteric Ischemia
Short Bowel Syndrome
Survey
| Study Type : | Observational |
| Estimated Enrollment : | 50 participants |
| Official Title : | Long-term Antithrombotic Management of Acute Mesenteric Ischaemia: Case-based Survey |
| Actual Study Start Date : | June 30, 2023 |
| Estimated Primary Completion Date : | February 29, 2024 |
| Estimated Study Completion Date : | February 29, 2024 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
University Hospitals Leuven
Leuven, Belgium, 3000